Pediatric Referral Through Norton EpicLink

If you are a medical provider, you can make a referral in real time and access your patient’s information instantly, all from anywhere you have web access, through Norton EpicLink.

If you are a patient looking to make an appointment with a Norton Children’s providerrequest an appointment online or call (502) 629-1234option 3.

If you already have a Norton EpicLink account, click on “Log In” below. If you are a provider and would like to request a Norton EpicLink account, click “New User Request” below. You will be contacted and asked to fill out security forms to gain access. Allow five to seven business days to process the request.

Norton EpicLink from Norton Children’s allows you to:

  • Refer a patient to Norton Children’s. Make referrals to Norton Children’s diagnostic services and specialty providers with Norton Children’s Medical Group, affiliated with the UofL School of Medicine.
  • View real-time referral status. Easily track the status of your pediatric referrals.
  • Help ensure continuity of care. Since Norton EpicLink is web-based, information is available almost instantly for any patient encounter across the Norton Children’s system, including hospitalizations, emergency visits and specialist referrals.
  • Safely communicate with providers. Securely send HIPAA-compliant messages to Norton Children’s providers.
  • Access patient information anywhere. With Norton EpicLink, you have view-only access anywhere you have internet service. View clinical data including radiology and procedure reports, hospital discharge summaries, current medication lists, patient demographics and coverage data.
  • Customize views and set notifications. Use filters to control what information you and your office staff see in Norton EpicLink and set up event notifications about your patients who access Norton Children’s services.
  • Manage MyClinic. You can designate a manager to add and delete your practice’s Norton EpicLink users.

Norton Children’s Direct Connect

  • Providers can speak with a Norton Children’s specialty provider.
  • Admit a patient to a Norton Children’s facility.
  • Schedule a patient for a diagnostic test.
  • Make a patient appointment with a specialty provider

Other

Get Our Monthly Newsletter

Stay informed on the latest offerings and treatments available at Norton Healthcare by subscribing to our monthly enewsletter.

Subscribe

Make a Referral

Partnering with you in caring for your patients.

Refer a Patient
Are You a Patient?
Provider Spotlight

Christopher P. Rhyne, M.D.

Christopher P. Rhyne, M.D., has joined Norton Neuroscience Institute as a headache medicine specialist.

Read More

Phase 1 cystic fibrosis trial studying novel enzyme replacement therapy in adults

Patients 18 years of age and older with cystic fibrosis now have an option of participating in a Phase 1 trial of a novel, broad-spectrum, orally delivered enzyme replacement therapy for cystic fibrosis (CF). The [...]

Read Full Story

Sciatic neuropathy case study: 4-centimeter tumor discovered on sciatic nerve

The patient A 64-year-old woman tripped after “missing a step,” fracturing her left tibial plateau and resulting in deformity of the joint. This was managed conservatively, with a leg brace removing weight from the extremity. [...]

Read Full Story

March 2024 Norton Children’s Medical Group New Providers

Pamela C Biddle, M.D. Pediatrics Jessica N.B. Easterling, M.D. Pediatrics Kelly E Kries, MD ­ Pediatrics Casey L Miles, MD Pediatrics Danielle R. Lunsford, APRN Developmental-Behavioral Pediatrics Mary C. Oechslin, APRN Pediatrics Chelsea R. Sabelhaus, […]

Read Full Story

March 2024 Norton Medical Group new providers

Paul A. Kniery, M.D. Internal Medicine Stephen Love, M.D. Behavioral Medicine Sarah A. Mayfield, M.D. Internal Medicine Emmanuel A. Nidhiry, M.D. Medical Oncology and Hematology Anupama Raghuram, M.D. Infectious Diseases Elizabeth Fahey, PA-C Hand Surgery […]

Read Full Story

Updated information on lecanemab infusions for mild cognitive impairment and Alzheimer’s

In 2023, the Food and Drug Administration (FDA) approved lecanemab (brand name Leqembi) for the treatment of Alzheimer’s disease. Lecanemab is the first widely used medication in a new class of anti-amyloid agents for the […]

Read Full Story

Search our entire site.